• Citer

The Lubumbashi Trial: Week 48 Data: Comparison between Lopinavir/r (LPV/r) versus Nevirapine (NVP)-based Regimens in Treatment-naïve Patients in a Developing Country

par Clumeck, Nathan ;Mwamba, C.;Kabeya, Kabamba ;Mafutamingi, J.;Vaira, Dolores;Ilunga, Kalembeyi;Necsoi, Coca Valentina ;Milolo, C.;De Wit, Stéphane ;Muyumba, E.;Moutschen, Michel;Kasamba, E.;Delforge, Marie-Luce ;Kapend, L.
Référence European AIDS Conference / EACS (13: October 12-15 2011: Belgrade, Serbia)
Publication Non publié, 2011-10

Communication à un colloque

• Détails

Titre:	The Lubumbashi Trial: Week 48 Data: Comparison between Lopinavir/r (LPV/r) versus Nevirapine (NVP)-based Regimens in Treatment-naïve Patients in a Developing Country
Auteur:	Clumeck, Nathan; Mwamba, C.; Kabeya, Kabamba; Mafutamingi, J.; Vaira, Dolores; Ilunga, Kalembeyi; Necsoi, Coca Valentina; Milolo, C.; De Wit, Stéphane; Muyumba, E.; Moutschen, Michel; Kasamba, E.; Delforge, Marie-Luce; Kapend, L.
Informations sur la publication:	European AIDS Conference / EACS (13: October 12-15 2011: Belgrade, Serbia)
Statut de publication:	Non publié, 2011-10
Sujet CREF:	Sciences bio-médicales et agricoles
	Pathologie maladies infectieuses
Langue:	Anglais